Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Where AI Meets It's Buyers.

The AI and Digitisation Zone at Discovery and Development Europe 2026 is where the companies building the future of drug discovery meet the scientists putting it to work.

Berlin. 15 - 16 June.

  

1,000 Senior Scientists and R&D Leaders. Two Days. One Building.

Discovery and Development Europe brings together the drug discovery and formulation science community in Berlin. Pharma, biotech and AI-driven drug discovery platforms. The people making platform decisions, evaluating technology partnerships and setting R&D strategy.
In 2026 the event reflects a fundamental shift in the field. AI is now embedded across the full drug discovery value chain. If your technology sits in AI drug discovery, automation, data infrastructure or computational biology — this is where your buyers are.

AI Digitisation Zone Image

The AI and Digitisation Zone

A dedicated space within the DDEU exhibition, purpose-built for AI-driven drug discovery, digital R&D and next-generation platform technologies. The Zone draws delegates throughout both days — not a pass-through, a destination. 

Live Demonstrations

Show your platform working. Not slides. The actual technology, running in real time, in front of the people who need to understand what it does.

Short Technology Talks

High-impact, focused presentations designed for a scientific audience with limited time and high standards. Five to ten minutes. One clear idea. The format that works for this community.

AI Networking Lounge

A dedicated space for informal conversation and hosted coffee. Designed to keep people in the Zone, not passing through it.

VR Formula 1 Experience

Set against the streets and landmarks of Berlin, the VR F1 driving experience is the social activation at the heart of the Zone. It draws delegates in, creates a reason to stay and generates repeated brand interactions across both days. Sponsor branding featured on the VR stations throughout.

Scheduled Demos During Lunch

Both Day 1 and Day 2 lunch breaks feature scheduled AI platform demos in the Zone — bringing a focused audience into the space at the highest-traffic moments of the day.

AI Zone Feature Images

Zone Sponsorship Options

Three levels of Zone sponsorship are available:

AI Zone Premium

AI Zone - Interactive Sessions

The headline Zone partnership. Exclusive naming rights to the AI and Digitisation Zone. A 20-minute presentation on the main conference programme. A keynote slot and live demo within the Zone. Branding on the VR F1 stations and the main Zone archway entrance. Full event marketing integration.

AI Zone Standard

AI Zone - Networking Hub

A focused Zone presence. A 5-minute presentation slot and live demo within the Zone. Exhibition presence in the AI hub. Event marketing inclusion.

AI Zone Coffee Cart

AI Zone - Coffee Connections

Brand your platform at the heart of Zone social activity. The barista coffee cart is the social anchor of the AI Networking Lounge, the most visited point in the Zone. Logo on the cart and on every recyclable cup served across both days.

All packages include exhibition presence within the Zone, inclusion in event marketing materials and access to the Discovery & Development Europe delegate community.

Pricing is available on request.

Confirmed Zone Sponsors Include:

Who You Will Meet

Traditional pharma R&D — the AstraZenecas, GSKs, Sanofis and Novartises. Integrating AI across discovery pipelines at enterprise scale. Evaluating platforms for target identification, data infrastructure, lab automation and computational chemistry.

Asset-centric and platform biotech — AI-embedded from the start. Often faster to evaluate and adopt new technology than large pharma counterparts.

AI-native drug developers — companies like Recursion, Insilico Medicine and BenevolentAI who are building the new paradigm. They attend to collaborate, benchmark and find pharma partners.

The Conversation Happening Around You

Your Zone presence sits inside a two-day scientific programme built entirely around the questions your technology answers. Keynote speakers include Dave Hallett, Chief Scientific Officer of Recursion, on the automation and AI landscape in 2026. Paul Workman OBE FRS of the Institute of Cancer Research on 25 years of precision medicine. Ingo Hartung of Merck Healthcare KGaA on moving beyond inhibitors.

Confirmed speakers from AstraZeneca, GSK, Sanofi, Novartis, Roche, Bayer, AbbVie, Novo Nordisk and Boehringer Ingelheim across tracks covering AI-guided drug discovery, automation, computational chemistry, screening, targeted protein degradation, ADC development and neuroscience.

There are also invite-only closed-door sessions for senior leaders on where smart capital is flowing in drug discovery, the real impact of AI on workflows, and the winning model for brain health innovation.
You are not adjacent to this programme. You are inside it.

The AI and Digitisation Zone is open to a select number of partners. If your technology belongs in this conversation, the next step is a 20-minute call.

Discovery and Development Europe 2026. Berlin, 15-16 June.